Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review
Christine Hsu(University of Pennsylvania), David E. Kaplan(Philadelphia VA Medical Center), Manfred Wiese(University Hospital Leipzig), Hwai‐I Yang(Chang Gung University), Kyong‐Mi Chang(Scripps Research Institute), Elizabeth C. Wright(National Institute of Diabetes and Digestive and Kidney Diseases), Maria Mironova(National Institutes of Health), Tomilowo Abijo(National Institute of Diabetes and Digestive and Kidney Diseases), Harish Gopalakrishna(National Institutes of Health), Mei–Hsuan Lee(National Yang Ming Chiao Tung University), Jordan J. Feld(University of Toronto), Chien‐Jen Chen(Genomics Research Center, Academia Sinica)
Cited by 12
Related Papers
Predicting Cirrhosis Risk Based on the Level of Circulating Hepatitis B Viral Load
|Gastroenterology|2006|1.5k
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
|New England Journal of Medicine|2013|1.1k
Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin
|New England Journal of Medicine|2014|907
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
|JNCI Journal of the National Cancer Institute|2005|569
Residual NADPH Oxidase and Survival in Chronic Granulomatous Disease
|New England Journal of Medicine|2010|560